Announcements

    Drinks

      FRIDAY, 29/12/2023 - Scope Ratings GmbH
      Download PDF

      Scope converts German Merck’s ratings into unsolicited subscription ratings available on ScopeOne

      Following Merck’s request for a withdrawal of Scope’s public ratings on the German conglomerate, the rating agency has converted all ratings into unsolicited subscription ratings.

      The latest information on the rating, including rating reports and related methodologies, is available on this LINK.

      Converted ratings relate to Merck KGaA (issuer rating, long-term and short-term debt ratings); Merck Financial Services GmbH (issuer rating, long-term debt rating), EMD Finance LLC (issuer rating, long-term debt rating).

      All of the following ratings are converted into unsolicited subscription ratings:

      • Issuer ratings and Outlook: A/Stable
         
      • Short-term debt rating: S-1
         
      • Long-term senior unsecured debt ratings: A
         
      • Long-term contractually subordinated (hybrid) debt ratings: BBB+
         

      Related news

      Show all
      Scope affirms Vöröskő’s issuer rating at BB/Stable

      12/12/2025 Rating announcement

      Scope affirms Vöröskő’s issuer rating at BB/Stable

      Scope affirms Akershus Energi’s issuer rating at A-/Stable

      12/12/2025 Rating announcement

      Scope affirms Akershus Energi’s issuer rating at A-/Stable

      Scope affirms B+/Stable issuer rating of Kopaszi Gát Zrt.

      11/12/2025 Rating announcement

      Scope affirms B+/Stable issuer rating of Kopaszi Gát Zrt.

      Scope affirms ENSI Kft.’s B+/Stable issuer rating

      10/12/2025 Rating announcement

      Scope affirms ENSI Kft.’s B+/Stable issuer rating

      Scope revises Outlook on FMCG company JCS Nikora’s BB- issuer rating to Stable from Negative

      10/12/2025 Rating announcement

      Scope revises Outlook on FMCG company JCS Nikora’s BB- issuer ...

      Scope has updated its analytical report on Sanofi S.A.

      9/12/2025 Monitoring note

      Scope has updated its analytical report on Sanofi S.A.